HONGSENG 0041 Share Price
RM1.62
52 Weeks Range : 0.135 - 1.88
3.6/10
(Expert Score)
Product is rated as #59 in category BM Technology
PROS:
- Positive Cash Company
- Very Low Gearing
- Very High Trading Value
CONS:
- Poor Income Near Future
- No Dividend Declared
- Very Low Price-to-Tangible
klse: Hong Seng Consolidated Berhad
Corporate Information
Board : Main
Shariah : Shariah Compliant
Sector : Information Technology Services
Packaged Software
Address: Gate C, 2nd Floor No 3, Jalan TP 2 Taman Perindustrian UEP 47600 Subang Jaya
Contact: +603-7890 3535
Website: https://hongseng.com.my
Corporate Background
Hong Seng Consolidated Berhad, (formerly named as MSCM Holdings Berhad/CBS Technology Berhad), an investment holding company, provides radio frequency identification (RFID), e-security, supply chain management, and enterprise productivity solutions in Malaysia
Genaral Info: HONGSENG 0041
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 28/05/21 | 56,429 | 13,134 | 6,026 |
| 25/02/21 | 25,294 | 7,112 | 3,035 |
| 27/11/20 | 530 | 1,429 | 1,429 |
| 21/08/20 | 528 | -1 | -1 |
| 18/06/20 | 337 | -8,241 | -8,216 |
| 27/02/20 | 749 | -579 | -574 |
| 28/11/19 | 1,323 | 951 | 943 |
| 30/08/19 | 2,021 | 412 | 412 |
| 30/05/19 | 983 | -7,552 | -8,070 |
| 25/02/19 | 3,989 | -6,183 | -6,125 |
| 21/11/18 | 2,723 | 250 | 250 |
| 29/08/18 | 2,813 | 861 | 873 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 82,781 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | 16,974 |
| Last 4 Quarter EPS (sen) | 1.82 |
| Last 4 Quarter PER | 108.89 |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | – |
| Net Tangible Assets (RM) | 0.19 |
| Goodwill (RM) | 0 |
| Cash (RM’000) | 67,950 |
| Debt (RM’000) | 1,280 |
| Total Debt (RM’000) | 16,240 |
| Net Assets (RM’000) | 96,000 |
| Current Ratio | 16.24 |
| Quick Ratio | 16.24 |
| Cash Ratio | 15.89 |
Technical
Technical Analysis
| MACD (26 vs 12) | 0.033 |
|---|---|
| Exponential Moving Average 5 | 1.628 |
| Exponential Moving Average 20 | 1.566 |
| Exponential Moving Average 90 | 1.457 |
| Relative Strength Index 14 | 0.76 |
| Stochastic %D 3 | 0.90 |
| Stochastic %K 14 | 0.94 |
4 reviews for HONGSENG 0041
Show all
Most Helpful
Highest Rating
Lowest Rating
The Edge –
Hong Seng Consolidated Bhd’s unit has bagged an RM34.25 million contract to supply polymerase chain reaction (PCR) test kits for Covid-19 to the Institute for Medical Research (IMR). The contract to supply the test kits to the Health Ministry’s institute is to be completed by March 1. The unit, Pantasniaga Sdn Bhd, is an authorised representative and distributor for BGI Genomics Co Ltd, which is a 51%-owned subsidiary of HS Bio Supplies Sdn Bhd, which in turn is a wholly-owned unit of Hong Seng.
The Star –
Hong Seng Consolidated Bhd, via its wholly-owned subsidiary HS Bio Supplies Sdn Bhd, has acquired 51% stake in Pantasniaga Sdn Bhd, which has been supplying polymerase chain reaction (PCR) test kits for Covid-19. As Pantasniaga has already performed and fulfilled a few supply contracts for Malaysian government agencies, Hong Seng said HS Bio would be continuing its support to procure and supply the PCR test kits with the ongoing outbreak in Malaysia, as well as neighbouring countries.
REMUNERATION STUDY –
In Financial Year End 2020, the directors’ remuneration was 0.66 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 2.7 million and auditor’s remuneration of 89 thousands
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 1.02 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 4.2 million and auditor’s remuneration of 108 thousands